CNBX PHARMACEUTICALS INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
CNBX PHARMACEUTICALS INC. (CNBX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $2.30 million for the 3-month period ending 2023-02-28, per its 10-Q filed 2024-04-16.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2024-04-16
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2023-02-28 was $2.30M.
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-11-30 was -$59.87K.
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2022-02-28 was -$366.79K.
- CNBX PHARMACEUTICALS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2021-11-30 was -$281.21K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month |
|---|---|---|
| 2023-02-28 | $2.30M 10-Q · filed 2024-04-16 | $2.24M 10-Q · filed 2024-04-16 |
| 2022-11-30 | -$59.87K 10-Q · filed 2023-01-13 | |
| 2022-02-28 | -$366.79K 10-Q · filed 2023-04-14 | -$648.00K 10-Q · filed 2023-04-14 |
| 2021-11-30 | -$281.21K 10-Q · filed 2023-01-13 |